These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 1528022)
1. X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect. Wanders RJ; van Roermund CW; Lageweg W; Jakobs BS; Schutgens RB; Nijenhuis AA; Tager JM J Inherit Metab Dis; 1992; 15(4):634-44. PubMed ID: 1528022 [TBL] [Abstract][Full Text] [Related]
2. Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy. Hashmi M; Stanley W; Singh I FEBS Lett; 1986 Feb; 196(2):247-50. PubMed ID: 3948997 [TBL] [Abstract][Full Text] [Related]
3. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658 [TBL] [Abstract][Full Text] [Related]
4. Peroxisomal fatty acid beta-oxidation in relation to adrenoleukodystrophy. Wanders RJ; Tager JM Dev Neurosci; 1991; 13(4-5):262-6. PubMed ID: 1817031 [TBL] [Abstract][Full Text] [Related]
5. X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters. Wanders RJ; van Roermund CW; van Wijland MJ; Nijenhuis AA; Tromp A; Schutgens RB; Brouwer-Kelder EM; Schram AW; Tager JM; van den Bosch H Clin Chim Acta; 1987 Jun; 165(2-3):321-9. PubMed ID: 3652454 [TBL] [Abstract][Full Text] [Related]
6. Immunochemical and biochemical studies of fatty acid oxidation in fibroblasts of Zellweger and X-linked adrenoleukodystrophy patients. Reubsaet FA; Veerkamp JH; Brückwilder ML; Trijbels JM; Hashimoto T; Monnens LA Biochim Biophys Acta; 1991 Jun; 1083(3):305-9. PubMed ID: 2049396 [TBL] [Abstract][Full Text] [Related]
8. X-linked adrenoleukodystrophy: identification of the primary defect at the level of a deficient peroxisomal very long chain fatty acyl-CoA synthetase using a newly developed method for the isolation of peroxisomes from skin fibroblasts. Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Schalkwijk C J Inherit Metab Dis; 1988; 11 Suppl 2():173-7. PubMed ID: 3141702 [No Abstract] [Full Text] [Related]
9. Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy. Chen WW; Watkins PA; Osumi T; Hashimoto T; Moser HW Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1425-8. PubMed ID: 3469675 [TBL] [Abstract][Full Text] [Related]
10. Pitfalls in the prenatal diagnosis of peroxisomal beta-oxidation defects by chorionic villus sampling. Carey WF; Poulos A; Sharp P; Nelson PV; Robertson EF; Hughes JL; Gill A Prenat Diagn; 1994 Sep; 14(9):813-9. PubMed ID: 7845889 [TBL] [Abstract][Full Text] [Related]
11. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants. Poulos A; Singh H; Paton B; Sharp P; Derwas N Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264 [TBL] [Abstract][Full Text] [Related]
12. The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. Contreras M; Mosser J; Mandel JL; Aubourg P; Singh I FEBS Lett; 1994 May; 344(2-3):211-5. PubMed ID: 8187886 [TBL] [Abstract][Full Text] [Related]
13. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders. Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128 [TBL] [Abstract][Full Text] [Related]
14. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders. Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624 [TBL] [Abstract][Full Text] [Related]
15. [X-chromosomal adrenoleukodystrophy. A peroxisomal disease important for differential diagnosis in the internal medicine-neurological field]. Wagdi P; Meier C Schweiz Med Wochenschr; 1990 Sep; 120(35):1247-52. PubMed ID: 2218446 [TBL] [Abstract][Full Text] [Related]
16. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency. Lazo O; Contreras M; Bhushan A; Stanley W; Singh I Arch Biochem Biophys; 1989 May; 270(2):722-8. PubMed ID: 2705786 [TBL] [Abstract][Full Text] [Related]
17. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Moser HW; Moser AE; Singh I; O'Neill BP Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872 [TBL] [Abstract][Full Text] [Related]
18. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts. Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146 [TBL] [Abstract][Full Text] [Related]
19. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527 [TBL] [Abstract][Full Text] [Related]
20. Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids. Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; van den Bosch H; Schram AW; Tager JM Biochem Biophys Res Commun; 1988 Jun; 153(2):618-24. PubMed ID: 3382393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]